Double-blind, placebo and active comparator-controlled study in Healthy Males followed by an open-label study in Healty Males and Females, to asses the safety, Pharmacokinetics and –dynamics of 2B3-201

Double-blind, placebo and active comparator-controlled study in Healthy Males followed by an open-label study in Healty Males and Females, to asses the safety, Pharmacokinetics and –dynamics of 2B3-201

Preclinical studies in animal models of MS showed that 2B3-201 had fewer side effects and a superior efficacy compared to free MP. Methods In this double-blind, 3-way cross over study, 18 healthy males in 3 cohorts, received an ascending doses of 2B3-201, active comparator (MP) or placebo.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical therapeutics 2015-08, Vol.37 (8), p.e80-e81
Hauptverfasser: Kanhai, K.M.S, Zuiker, R.G.J.A, Gladdines, W, Stevens, J, Stavrakaki, I, Groeneveld, G.J
Format: Artikel
Sprache:eng
Schlagworte:
Internal Medicine
Medical Education
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Preclinical studies in animal models of MS showed that 2B3-201 had fewer side effects and a superior efficacy compared to free MP. Methods In this double-blind, 3-way cross over study, 18 healthy males in 3 cohorts, received an ascending doses of 2B3-201, active comparator (MP) or placebo.
ISSN:0149-2918
1879-114X
DOI:10.1016/j.clinthera.2015.05.232